Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies <i>SMARCAL1</i> as a Novel Osteosarcoma Predisposition Gene

Our study confirms the relevance DDR genetic variation in pediatric cancer risk and establishes <i>SMARCAL1</i> as a novel OS predisposing gene, providing insights into tumor biology and creating opportunities to optimize care for patients with this challenging tumor.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-10-09
DOI
https://doi.org/10.1200/jco-25-01114
Citations
3
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
5.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene

Kristian W. Pajtler, Ninad Oak, Lynn Harrison, Michaela Nathrath et al.
3 citations
Journal of Clinical Oncology
Acute Lymphoblastic Leukemia research
5.64
article

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene

Kristian W. Pajtler, Ninad Oak, Lynn Harrison, Michaela Nathrath, Steffen Hirsch, Jiaming Li, Greg Armstrong, Kim E. Nichols, Gang Wu, Robert J. Autry, Alise K. Blake, Yadav Sapkota, Kirsten K. Ness, Stefan M. Pfister, Uta Dirksen, Wenan Chen, Christopher Previti, Christian P. Kratz, Judith Penkert, Lillian M. Guenther, Kendra K. Maaß, Gnanaprakash Balasubramanian, Melissa M. Hudson, David Jones, Richa Sharma, Zhaoming Wang, Olaf Witt, Barbara C. Jones, Kathrin Schramm, Martha A. O’Brien
article en
3 citations

Abstract

Our study confirms the relevance DDR genetic variation in pediatric cancer risk and establishes <i>SMARCAL1</i> as a novel OS predisposing gene, providing insights into tumor biology and creating opportunities to optimize care for patients with this challenging tumor.

Journal of Clinical OncologyVol. 43(36)
St. Jude Children's Research Hospital (US), Mayo Clinic (US), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), Medizinische Hochschule Hannover (DE), German Cancer Society (DE), Center for Cancer and Blood Disorders (US), National Center for Tumor Diseases (DE), Hopp Children's Cancer Center Heidelberg (DE), Essen University Hospital (DE), Deutsche Montan Technologie (Germany) (DE), West German Heart and Vascular Center Essen (DE), Deutsches Konsortium für Translationale Krebsforschung (DE)
Openalex Percentile: Top 4%
Acute Lymphoblastic Leukemia research
5.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.